+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Artificial Urinary Sphincters Market - Global Forecast 2026-2032- Product Image
Artificial Urinary Sphincters Market - Global Forecast 2026-2032- Product Image
Sale

Artificial Urinary Sphincters Market - Global Forecast 2026-2032

  • Report

  • 199 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 4896636
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Artificial Urinary Sphincters Market is projected to reach USD 497.51 Million in 2026. It is expected to continue growing at a CAGR of 7.46%, reaching USD 763.18 Million by 2032.

Artificial urinary sphincters (AUS) are implantable continence devices used primarily for moderate-to-severe stress urinary incontinence, especially in men after prostate cancer treatment or other sphincter-compromising surgery. The category is clinically important because stress urinary incontinence can limit mobility, work participation, sleep, mental health, and long-term quality of life, creating a sustained need for reliable urological implants and reconstructive continence care.

In urology guidelines and peer-reviewed clinical practice, the AUS remains the reference standard for appropriately selected men with severe post-prostatectomy incontinence. Demand is shaped by aging populations, prostate cancer survivorship, higher expectations for quality-of-life restoration, and broader access to reconstructive urology. Growth is also tied to surgeon training, reimbursement coverage, infection-control protocols, and device durability, because artificial urinary sphincter implantation requires specialized patient selection, operative skill, patient education on device use, and lifelong follow-up for revision, infection, erosion, or mechanical performance concerns.

Transformative Shifts in the AUS Landscape

The artificial urinary sphincter landscape is shifting from procedure availability toward measurable outcomes, patient-reported improvement, and lifecycle management. Hospitals and ambulatory surgery centers are increasingly evaluated on complication reduction, readmission avoidance, infection prevention, and long-term device performance, making preoperative counseling and post-implant surveillance central to adoption of AUS surgery.

Technology adoption is also changing. Established hydraulic cuff systems remain the benchmark, while innovation is focused on easier activation, improved cuff design, pressure optimization, antibiotic-conscious workflows, and materials intended to reduce erosion and infection risk. The market is also influenced by the rise of male sling alternatives for selected patients, growing salvage surgery needs after pelvic radiation, greater attention to frailty and comorbidities in older patients, and wider use of telehealth for follow-up. These shifts favor stakeholders that combine durable implants, urologist education, real-world evidence generation, and structured patient support.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is not replacing the artificial urinary sphincter, but it is beginning to influence the care pathway around AUS candidates. AI-enabled analytics can support risk stratification by integrating age, prior radiation, diabetes, urethral surgery history, anticoagulation status, mobility, cognitive readiness for device operation, and severity of leakage to identify patients who may need enhanced counseling or specialized reconstructive expertise.

In clinical operations, machine learning can help forecast operating room demand, revision risk, inventory needs, and follow-up adherence. Natural language processing can extract continence outcomes, pad usage, patient-reported satisfaction, and adverse events from clinical notes, improving real-world evidence generation. AI may also support remote monitoring programs by flagging patients reporting pain, voiding difficulty, recurrent leakage, hematuria, or signs of infection. The cumulative impact is a more data-driven AUS ecosystem, where patient selection, outcome tracking, surgical planning, and revision management become more precise and scalable.

Key Regional Insights: Asia-Pacific, North America, Latin America, Europe, Middle East, and Africa

North America remains the most established regional market for artificial urinary sphincters, supported by high prostate cancer survivorship, advanced reconstructive urology networks, and broad use of guideline-based treatment pathways. The region benefits from academic medical centers, ambulatory surgical capacity, structured continence care, and established reimbursement mechanisms for implantable urological devices. The United States is especially important because large urology groups, tertiary hospitals, cancer survivorship programs, and private and public payers create a structured environment for AUS implantation, revision surgery, infection management, and outcomes research, while Canada’s access is shaped by publicly funded care pathways and provincial surgical capacity.

Europe shows mature demand for artificial urinary sphincters, with adoption concentrated in countries that have strong public reimbursement, specialized pelvic reconstructive urology, and centralized prostate cancer care. The European clinical environment emphasizes device safety, post-market surveillance, clinical evidence, and standardized quality systems. Asia-Pacific is expanding as Japan, Australia, South Korea, China, India, and ASEAN economies increase access to prostate cancer treatment, functional urology services, and tertiary surgical infrastructure, although adoption varies significantly by reimbursement, patient affordability, procurement processes, and surgeon training. Latin America, the Middle East, and Africa represent longer-term opportunities, led by private hospitals, government-funded specialty centers, and tertiary academic institutions; however, affordability, procurement reliability, specialist availability, revision-care capacity, and follow-up infrastructure remain key constraints to broader AUS adoption.

Key Group Insights: ASEAN, GCC, European Union, BRICS, G7, and NATO

Within the European Union and G7, artificial urinary sphincter demand is supported by aging demographics, high prostate cancer diagnosis and treatment rates, established health technology assessment processes, and access to reconstructive urologists. These markets place strong emphasis on clinical evidence, device safety, surgeon credentialing, reimbursement justification, infection prevention, and post-market surveillance. NATO membership itself is not a healthcare purchasing framework, but many NATO countries overlap with high-income markets where standardized procurement, hospital quality systems, military and veteran healthcare networks, and advanced continence-care pathways can influence access to AUS implantation and revision services.

BRICS countries offer significant procedural potential because of large populations, expanding cancer care, and rising investment in specialty surgery, but adoption is uneven due to reimbursement gaps, out-of-pocket exposure, and concentration of reconstructive urology expertise in major cities. ASEAN markets are developing through private-sector growth, medical tourism hubs, and expanding tertiary urology capacity, while access remains differentiated by income level and availability of trained implanting surgeons. GCC countries benefit from government-funded tertiary care, high investment in advanced urology services, and referral-based specialist hospitals, making them important centers for premium implantable urology technologies where procurement, clinician training, and long-term service support are clearly established.

Key Country Insights Across Major AUS Markets

The United States is the leading country market for artificial urinary sphincters because of high procedural specialization, extensive prostate cancer survivorship care, broad reconstructive urology expertise, and a strong base of implanting urologists. Canada follows with publicly funded access shaped by provincial capacity, referral patterns, and wait times. Mexico and Brazil show demand in private hospitals, major academic centers, and metropolitan specialty clinics where reconstructive urology and implantable device procurement are available. In Latin America, access is closely linked to private insurance, urban specialty concentration, and the ability to support long-term revision care.

In Europe, the United Kingdom, Germany, France, Italy, and Spain benefit from structured prostate cancer pathways, aging male populations, and experienced urology centers, although reimbursement approval, waiting lists, and regional access differ by system. Germany and France have strong specialist hospital networks, the United Kingdom emphasizes guideline-based continence management within public care, and Italy and Spain combine public hospital pathways with experienced regional centers. Russia has demand concentrated in large urban specialty hospitals where implant access and reconstructive expertise are available. In Asia-Pacific, Japan, Australia, and South Korea have advanced urology infrastructure, aging populations, and mature cancer survivorship services, while China and India represent high-potential markets where scale is significant but access depends on affordability, trained surgeons, tertiary-care availability, reimbursement expansion, and patient awareness of post-prostatectomy incontinence treatment options.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize evidence-based differentiation rather than relying only on device familiarity. The most defensible strategy is to generate long-term real-world data on continence improvement, revision rates, infection, erosion, device survival, patient satisfaction, pad-use reduction, and cost of care across diverse patient groups, including men with prior radiation, diabetes, urethral stricture history, or complex reconstructive needs.

Manufacturers and healthcare stakeholders should invest in surgeon education, proctoring, standardized implantation protocols, infection-control pathways, revision readiness, and patient activation training because AUS outcomes depend heavily on technique, appropriate selection, and follow-up. Commercial teams should align with reconstructive urology centers, cancer survivorship programs, continence clinics, and payers using value narratives that emphasize quality-of-life restoration and reduced dependence on pads or external containment. In emerging markets, success will require tiered access strategies, local distributor quality control, repair or revision support, responsible inventory management, and clear patient-selection guidance that reduces complications and supports sustainable adoption.

Research Methodology

This executive summary is built from a structured review of evidence-based sources commonly used in medical device market assessment, including urology society guidance, peer-reviewed studies on artificial urinary sphincter outcomes, regulatory and reimbursement context, hospital adoption patterns, prostate cancer survivorship trends, demographic aging indicators, and regional healthcare infrastructure evidence.

The analysis emphasizes verified clinical and market drivers rather than speculative market sizing. It evaluates demand through disease burden, treatment pathway maturity, specialist availability, reimbursement feasibility, device lifecycle needs, patient suitability, revision requirements, and real-world barriers to access. Regional, group, and country insights were synthesized by comparing healthcare capacity, urology specialization, cancer survivorship infrastructure, procurement dynamics, affordability, and follow-up systems relevant to AUS implantation and revision care.

Conclusion: The Future of Artificial Urinary Sphincters

Artificial urinary sphincters occupy a durable and clinically validated position in the management of severe stress urinary incontinence, particularly after prostate cancer treatment. The market’s long-term relevance is supported by aging populations, survivorship-focused urology, patient demand for restored continence, and the continued need for specialized reconstructive solutions when conservative measures or less invasive procedures are insufficient.

The strongest opportunities will come from pairing proven device performance with better patient selection, surgeon training, outcomes analytics, and regional access strategies. As artificial intelligence, real-world evidence, and value-based care mature, AUS stakeholders that demonstrate measurable quality-of-life benefit, durable safety, responsible lifecycle support, and reliable revision-care pathways will be best positioned to lead in artificial urinary sphincter innovation and adoption.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Artificial Urinary Sphincters Market, by Product Type
7.1. Introduction
7.2. Single-Cuff Artificial Urinary Sphincters
7.3. Dual-Cuff Artificial Urinary Sphincters
8. Artificial Urinary Sphincters Market, by Component Type
8.1. Introduction
8.2. Occlusive Cuff
8.3. Pressure-Regulating Balloon
8.4. Control Pump
8.5. Electronic Control Unit
9. Artificial Urinary Sphincters Market, by Mechanism of Action
9.1. Introduction
9.2. Hydraulic Pressure Control
9.3. Mechanical Compression Systems
9.4. Electromechanical / Sensor-Controlled Systems
10. Artificial Urinary Sphincters Market, by Material Type
10.1. Introduction
10.2. Silicone
10.3. Polyurethane
10.4. Biocompatible Polymers
11. Artificial Urinary Sphincters Market, by Gender
11.1. Introduction
11.2. Female
11.3. Male
12. Artificial Urinary Sphincters Market, by Distribution Channel
12.1. Introduction
12.2. Direct Sales
12.3. Distributors
12.4. Online Sales
13. Artificial Urinary Sphincters Market, by Application
13.1. Introduction
13.2. Neurogenic Bladder Dysfunction
13.3. Stress Urinary Incontinence
14. Artificial Urinary Sphincters Market, by End User
14.1. Introduction
14.2. Ambulatory Surgical Centers
14.2.1. Freestanding
14.2.2. Hospital Affiliated
14.3. Clinics
14.3.1. Multispecialty Clinics
14.3.2. Urology Clinics
14.4. Hospitals
14.4.1. Private Hospitals
14.4.2. Public Hospitals
15. Artificial Urinary Sphincters Market, by Region
15.1. Asia-Pacific
15.2. North America
15.3. Latin America
15.4. Europe
15.5. Middle East
15.6. Africa
16. Artificial Urinary Sphincters Market, by Group
16.1. ASEAN
16.2. GCC
16.3. European Union
16.4. BRICS
16.5. G7
16.6. NATO
17. Artificial Urinary Sphincters Market, by Country
17.1. United States
17.2. Canada
17.3. Mexico
17.4. Brazil
17.5. United Kingdom
17.6. Germany
17.7. France
17.8. Russia
17.9. Italy
17.10. Spain
17.11. China
17.12. India
17.13. Japan
17.14. Australia
17.15. South Korea
18. Competitive Landscape
18.1. Market Share Analysis, 2025
18.2. FPNV Positioning Matrix, 2025
18.3. Market Concentration Analysis, 2025
18.3.1. Concentration Ratio (CR)
18.3.2. Herfindahl Hirschman Index (HHI)
18.4. Recent Developments & Impact Analysis, 2025
18.5. Product Portfolio Analysis, 2025
18.6. Benchmarking Analysis, 2025
19. Company Profiles
19.1. Affluent Medical
19.2. Albyn Medical Ltd.
19.3. Andromeda Medizinische Systeme GmbH
19.4. Anhui Longterm Medical Products Co., Ltd.
19.5. Boston Scientific Corporation
19.6. Dualis MedTech GmbH
19.7. GT Urological LLC
19.8. LABORIE Medical Technologies Inc.
19.9. MyoPowers Medical Technologies SAS
19.10. Promedon S.A.
19.11. Rigicon Inc.
19.12. Uromedical AG
19.13. UroMems
19.14. Zephyr Surgical Implants AG
List of Figures
FIGURE 1. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY COMPONENT TYPE, 2025 VS 2032 (%)
FIGURE 9. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY COMPONENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MECHANISM OF ACTION, 2025 VS 2032 (%)
FIGURE 11. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MECHANISM OF ACTION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2032 (%)
FIGURE 13. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY GENDER, 2025 VS 2032 (%)
FIGURE 15. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY GENDER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 17. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 19. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 21. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 23. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 25. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 27. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 28. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 29. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL SINGLE-CUFF ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL SINGLE-CUFF ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL SINGLE-CUFF ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL DUAL-CUFF ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL DUAL-CUFF ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL DUAL-CUFF ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY COMPONENT TYPE, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL OCCLUSIVE CUFF MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL OCCLUSIVE CUFF MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL OCCLUSIVE CUFF MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL PRESSURE-REGULATING BALLOON MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL PRESSURE-REGULATING BALLOON MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL PRESSURE-REGULATING BALLOON MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL CONTROL PUMP MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL CONTROL PUMP MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL CONTROL PUMP MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL ELECTRONIC CONTROL UNIT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL ELECTRONIC CONTROL UNIT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL ELECTRONIC CONTROL UNIT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MECHANISM OF ACTION, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL HYDRAULIC PRESSURE CONTROL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL HYDRAULIC PRESSURE CONTROL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL HYDRAULIC PRESSURE CONTROL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL MECHANICAL COMPRESSION SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL MECHANICAL COMPRESSION SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL MECHANICAL COMPRESSION SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL ELECTROMECHANICAL / SENSOR-CONTROLLED SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL ELECTROMECHANICAL / SENSOR-CONTROLLED SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL ELECTROMECHANICAL / SENSOR-CONTROLLED SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL SILICONE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL SILICONE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL SILICONE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL POLYURETHANE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL POLYURETHANE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL POLYURETHANE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL BIOCOMPATIBLE POLYMERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL BIOCOMPATIBLE POLYMERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL BIOCOMPATIBLE POLYMERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY GENDER, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL FEMALE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL FEMALE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL FEMALE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL MALE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL MALE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL MALE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL DIRECT SALES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL DIRECT SALES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL DIRECT SALES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL DISTRIBUTORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL DISTRIBUTORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL DISTRIBUTORS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL ONLINE SALES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL ONLINE SALES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL ONLINE SALES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL NEUROGENIC BLADDER DYSFUNCTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL NEUROGENIC BLADDER DYSFUNCTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL NEUROGENIC BLADDER DYSFUNCTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL STRESS URINARY INCONTINENCE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL STRESS URINARY INCONTINENCE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL STRESS URINARY INCONTINENCE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL FREESTANDING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL FREESTANDING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL FREESTANDING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL HOSPITAL AFFILIATED MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL HOSPITAL AFFILIATED MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL HOSPITAL AFFILIATED MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL MULTISPECIALTY CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL MULTISPECIALTY CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL MULTISPECIALTY CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL UROLOGY CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL UROLOGY CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL UROLOGY CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL PRIVATE HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL PRIVATE HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL PRIVATE HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL PUBLIC HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL PUBLIC HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL PUBLIC HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 96. ASIA-PACIFIC ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 97. ASIA-PACIFIC ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 98. ASIA-PACIFIC ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY COMPONENT TYPE, 2017-2032 (USD MILLION)
TABLE 99. ASIA-PACIFIC ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MECHANISM OF ACTION, 2017-2032 (USD MILLION)
TABLE 100. ASIA-PACIFIC ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 101. ASIA-PACIFIC ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY GENDER, 2017-2032 (USD MILLION)
TABLE 102. ASIA-PACIFIC ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 103. ASIA-PACIFIC ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 104. ASIA-PACIFIC ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 105. ASIA-PACIFIC ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2017-2032 (USD MILLION)
TABLE 106. ASIA-PACIFIC ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 107. ASIA-PACIFIC ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 108. NORTH AMERICA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 109. NORTH AMERICA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 110. NORTH AMERICA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY COMPONENT TYPE, 2017-2032 (USD MILLION)
TABLE 111. NORTH AMERICA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MECHANISM OF ACTION, 2017-2032 (USD MILLION)
TABLE 112. NORTH AMERICA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 113. NORTH AMERICA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY GENDER, 2017-2032 (USD MILLION)
TABLE 114. NORTH AMERICA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 115. NORTH AMERICA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 116. NORTH AMERICA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 117. NORTH AMERICA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2017-2032 (USD MILLION)
TABLE 118. NORTH AMERICA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 119. NORTH AMERICA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 120. LATIN AMERICA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 121. LATIN AMERICA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 122. LATIN AMERICA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY COMPONENT TYPE, 2017-2032 (USD MILLION)
TABLE 123. LATIN AMERICA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MECHANISM OF ACTION, 2017-2032 (USD MILLION)
TABLE 124. LATIN AMERICA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 125. LATIN AMERICA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY GENDER, 2017-2032 (USD MILLION)
TABLE 126. LATIN AMERICA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 127. LATIN AMERICA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 128. LATIN AMERICA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 129. LATIN AMERICA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2017-2032 (USD MILLION)
TABLE 130. LATIN AMERICA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 131. LATIN AMERICA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 132. EUROPE ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 133. EUROPE ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 134. EUROPE ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY COMPONENT TYPE, 2017-2032 (USD MILLION)
TABLE 135. EUROPE ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MECHANISM OF ACTION, 2017-2032 (USD MILLION)
TABLE 136. EUROPE ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 137. EUROPE ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY GENDER, 2017-2032 (USD MILLION)
TABLE 138. EUROPE ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 139. EUROPE ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 140. EUROPE ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 141. EUROPE ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2017-2032 (USD MILLION)
TABLE 142. EUROPE ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 143. EUROPE ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 144. MIDDLE EAST ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 145. MIDDLE EAST ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 146. MIDDLE EAST ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY COMPONENT TYPE, 2017-2032 (USD MILLION)
TABLE 147. MIDDLE EAST ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MECHANISM OF ACTION, 2017-2032 (USD MILLION)
TABLE 148. MIDDLE EAST ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 149. MIDDLE EAST ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY GENDER, 2017-2032 (USD MILLION)
TABLE 150. MIDDLE EAST ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 151. MIDDLE EAST ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 152. MIDDLE EAST ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 153. MIDDLE EAST ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2017-2032 (USD MILLION)
TABLE 154. MIDDLE EAST ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 155. MIDDLE EAST ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 156. AFRICA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 157. AFRICA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 158. AFRICA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY COMPONENT TYPE, 2017-2032 (USD MILLION)
TABLE 159. AFRICA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MECHANISM OF ACTION, 2017-2032 (USD MILLION)
TABLE 160. AFRICA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 161. AFRICA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY GENDER, 2017-2032 (USD MILLION)
TABLE 162. AFRICA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 163. AFRICA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 164. AFRICA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 165. AFRICA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2017-2032 (USD MILLION)
TABLE 166. AFRICA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 167. AFRICA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 168. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 169. ASEAN ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 170. ASEAN ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 171. ASEAN ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY COMPONENT TYPE, 2017-2032 (USD MILLION)
TABLE 172. ASEAN ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MECHANISM OF ACTION, 2017-2032 (USD MILLION)
TABLE 173. ASEAN ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 174. ASEAN ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY GENDER, 2017-2032 (USD MILLION)
TABLE 175. ASEAN ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 176. ASEAN ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 177. ASEAN ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 178. ASEAN ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2017-2032 (USD MILLION)
TABLE 179. ASEAN ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 180. ASEAN ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 181. GCC ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 182. GCC ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 183. GCC ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY COMPONENT TYPE, 2017-2032 (USD MILLION)
TABLE 184. GCC ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MECHANISM OF ACTION, 2017-2032 (USD MILLION)
TABLE 185. GCC ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 186. GCC ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY GENDER, 2017-2032 (USD MILLION)
TABLE 187. GCC ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 188. GCC ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 189. GCC ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 190. GCC ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2017-2032 (USD MILLION)
TABLE 191. GCC ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 192. GCC ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 193. EUROPEAN UNION ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 194. EUROPEAN UNION ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 195. EUROPEAN UNION ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY COMPONENT TYPE, 2017-2032 (USD MILLION)
TABLE 196. EUROPEAN UNION ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MECHANISM OF ACTION, 2017-2032 (USD MILLION)
TABLE 197. EUROPEAN UNION ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 198. EUROPEAN UNION ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY GENDER, 2017-2032 (USD MILLION)
TABLE 199. EUROPEAN UNION ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 200. EUROPEAN UNION ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 201. EUROPEAN UNION ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 202. EUROPEAN UNION ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2017-2032 (USD MILLION)
TABLE 203. EUROPEAN UNION ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 204. EUROPEAN UNION ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 205. BRICS ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 206. BRICS ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 207. BRICS ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY COMPONENT TYPE, 2017-2032 (USD MILLION)
TABLE 208. BRICS ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MECHANISM OF ACTION, 2017-2032 (USD MILLION)
TABLE 209. BRICS ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 210. BRICS ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY GENDER, 2017-2032 (USD MILLION)
TABLE 211. BRICS ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 212. BRICS ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 213. BRICS ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 214. BRICS ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2017-2032 (USD MILLION)
TABLE 215. BRICS ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 216. BRICS ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 217. G7 ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 218. G7 ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 219. G7 ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY COMPONENT TYPE, 2017-2032 (USD MILLION)
TABLE 220. G7 ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MECHANISM OF ACTION, 2017-2032 (USD MILLION)
TABLE 221. G7 ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 222. G7 ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY GENDER, 2017-2032 (USD MILLION)
TABLE 223. G7 ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 224. G7 ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 225. G7 ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 226. G7 ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2017-2032 (USD MILLION)
TABLE 227. G7 ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 228. G7 ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 229. NATO ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 230. NATO ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 231. NATO ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY COMPONENT TYPE, 2017-2032 (USD MILLION)
TABLE 232. NATO ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MECHANISM OF ACTION, 2017-2032 (USD MILLION)
TABLE 233. NATO ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 234. NATO ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY GENDER, 2017-2032 (USD MILLION)
TABLE 235. NATO ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 236. NATO ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 237. NATO ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 238. NATO ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2017-2032 (USD MILLION)
TABLE 239. NATO ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 240. NATO ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 241. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 242. UNITED STATES ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 243. UNITED STATES ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 244. UNITED STATES ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY COMPONENT TYPE, 2017-2032 (USD MILLION)
TABLE 245. UNITED STATES ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MECHANISM OF ACTION, 2017-2032 (USD MILLION)
TABLE 246. UNITED STATES ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 247. UNITED STATES ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY GENDER, 2017-2032 (USD MILLION)
TABLE 248. UNITED STATES ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 249. UNITED STATES ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 250. UNITED STATES ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 251. UNITED STATES ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2017-2032 (USD MILLION)
TABLE 252. UNITED STATES ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 253. UNITED STATES ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 254. CANADA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 255. CANADA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 256. CANADA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY COMPONENT TYPE, 2017-2032 (USD MILLION)
TABLE 257. CANADA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MECHANISM OF ACTION, 2017-2032 (USD MILLION)
TABLE 258. CANADA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 259. CANADA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY GENDER, 2017-2032 (USD MILLION)
TABLE 260. CANADA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 261. CANADA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 262. CANADA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 263. CANADA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2017-2032 (USD MILLION)
TABLE 264. CANADA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 265. CANADA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 266. MEXICO ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 267. MEXICO ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 268. MEXICO ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY COMPONENT TYPE, 2017-2032 (USD MILLION)
TABLE 269. MEXICO ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MECHANISM OF ACTION, 2017-2032 (USD MILLION)
TABLE 270. MEXICO ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 271. MEXICO ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY GENDER, 2017-2032 (USD MILLION)
TABLE 272. MEXICO ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 273. MEXICO ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 274. MEXICO ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 275. MEXICO ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2017-2032 (USD MILLION)
TABLE 276. MEXICO ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 277. MEXICO ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 278. BRAZIL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 279. BRAZIL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 280. BRAZIL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY COMPONENT TYPE, 2017-2032 (USD MILLION)
TABLE 281. BRAZIL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MECHANISM OF ACTION, 2017-2032 (USD MILLION)
TABLE 282. BRAZIL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 283. BRAZIL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY GENDER, 2017-2032 (USD MILLION)
TABLE 284. BRAZIL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 285. BRAZIL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 286. BRAZIL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 287. BRAZIL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2017-2032 (USD MILLION)
TABLE 288. BRAZIL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 289. BRAZIL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 290. UNITED KINGDOM ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 291. UNITED KINGDOM ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 292. UNITED KINGDOM ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY COMPONENT TYPE, 2017-2032 (USD MILLION)
TABLE 293. UNITED KINGDOM ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MECHANISM OF ACTION, 2017-2032 (USD MILLION)
TABLE 294. UNITED KINGDOM ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 295. UNITED KINGDOM ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY GENDER, 2017-2032 (USD MILLION)
TABLE 296. UNITED KINGDOM ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 297. UNITED KINGDOM ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 298. UNITED KINGDOM ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 299. UNITED KINGDOM ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2017-2032 (USD MILLION)
TABLE 300. UNITED KINGDOM ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 301. UNITED KINGDOM ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 302. GERMANY ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 303. GERMANY ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 304. GERMANY ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY COMPONENT TYPE, 2017-2032 (USD MILLION)
TABLE 305. GERMANY ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MECHANISM OF ACTION, 2017-2032 (USD MILLION)
TABLE 306. GERMANY ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 307. GERMANY ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY GENDER, 2017-2032 (USD MILLION)
TABLE 308. GERMANY ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 309. GERMANY ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 310. GERMANY ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 311. GERMANY ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2017-2032 (USD MILLION)
TABLE 312. GERMANY ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 313. GERMANY ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 314. FRANCE ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 315. FRANCE ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 316. FRANCE ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY COMPONENT TYPE, 2017-2032 (USD MILLION)
TABLE 317. FRANCE ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MECHANISM OF ACTION, 2017-2032 (USD MILLION)
TABLE 318. FRANCE ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 319. FRANCE ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY GENDER, 2017-2032 (USD MILLION)
TABLE 320. FRANCE ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 321. FRANCE ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 322. FRANCE ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 323. FRANCE ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2017-2032 (USD MILLION)
TABLE 324. FRANCE ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 325. FRANCE ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 326. RUSSIA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 327. RUSSIA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 328. RUSSIA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY COMPONENT TYPE, 2017-2032 (USD MILLION)
TABLE 329. RUSSIA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MECHANISM OF ACTION, 2017-2032 (USD MILLION)
TABLE 330. RUSSIA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 331. RUSSIA ARTIFICIAL URINARY SPHINCTERS

Companies Mentioned

  • Affluent Medical
  • Albyn Medical Ltd.
  • Andromeda Medizinische Systeme GmbH
  • Anhui Longterm Medical Products Co., Ltd.
  • Boston Scientific Corporation
  • Dualis MedTech GmbH
  • GT Urological LLC
  • LABORIE Medical Technologies Inc.
  • MyoPowers Medical Technologies SAS
  • Promedon S.A.
  • Rigicon Inc.
  • Uromedical AG
  • UroMems
  • Zephyr Surgical Implants AG

Table Information

Report AttributeDetails
No. of Pages199
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 497.51 Million
Forecasted Market Value ( USD ) by 2032 $ 763.18 Million
Compound Annual Growth Rate7.4%
Regions CoveredGlobal
No. of Companies Mentioned14

Related Topics

Related Reports

Male Artificial Urinary Sphincter - Global Strategic Business Report - Product Image

Male Artificial Urinary Sphincter - Global Strategic Business Report

  • Report
  • 266 Pages
  • Global
From
Artificial Urinary Sphincters - Global Strategic Business Report - Product Image

Artificial Urinary Sphincters - Global Strategic Business Report

  • Report
  • 146 Pages
  • Global
From
Male Artificial Urinary Sphincter Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F - Product Image

Male Artificial Urinary Sphincter Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

  • Report
  • 180 Pages
  • Global
From
Stress Urinary Incontinence Devices - Market Insights, Competitive Landscape, and Market Forecast - 2034 - Product Image

Stress Urinary Incontinence Devices - Market Insights, Competitive Landscape, and Market Forecast - 2034

  • Report
  • 150 Pages
  • Global
From
Urinary Incontinence Device Market - Global Forecast 2026-2032 - Product Image

Urinary Incontinence Device Market - Global Forecast 2026-2032

  • Report
  • 191 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.